ANRO (Alto Neuroscience Inc.) Stock Analysis - Hedge Fund Holdings
Alto Neuroscience Inc. (ANRO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANRO trades at $20.77 with a market cap of $765.05M and a P/E ratio of -8.22. ANRO moved +1.71% today. Year to date, ANRO is +25.71%; over the trailing twelve months it is +614.09%. Its 52-week range spans $1.60 to $28.44. Analyst consensus is strong buy with an average price target of $35.22. Rallies surfaces ANRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns ANRO stock?
Hedge funds tracked by Rallies that own ANRO include Orbimed Advisors and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Alto Neuroscience Inc..
ANRO Key Metrics
Key financial metrics for ANRO
Metric
Value
Price
$20.77
Market Cap
$765.05M
P/E Ratio
-8.22
EPS
$-2.50
Dividend Yield
0.00%
52-Week High
$28.44
52-Week Low
$1.60
Volume
2
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-61.43M
Gross Margin
0.00%
Top Hedge Funds Holding ANRO
Orbimed Advisors holds 167.50K shares of ANRO, changed +34.00% as of Mar 31, 2026.
Polen Capital holds 16.61K shares of ANRO, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own ANRO include Orbimed Advisors and Polen Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Alto Neuroscience Inc..
Does Rallies show 13F holders for ANRO?
Yes. Rallies tracks hedge fund and 13F ownership data for ANRO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ANRO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ANRO. It does not provide personalized investment advice.
